Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,132 Diabetes
clinical trials

Endocrinology Clinical Trial
Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials
Pompe Disease Clinical Trial
Alglucosidase Alfa Pompe Safety Sub-Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Gent,
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
Canal Fulton, OH
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
Chandler, AZ
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
Covington, LA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
Dearborn, MI
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
East Greenhich, RI
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
Greenfield, IN
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
Greer, SC
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
Huntington Park, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
Inglewood, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
Lake Clarke Shores, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
Lodi, NJ
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
Lomita, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
Lynn Haven, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
McKinney, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
Nashua, NH
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
Rochester, MI
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
Staten Island, NY
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
Summerville, SC
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
Tarzana, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
Tipton, PA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Status: Enrolling, Phase III
Updated: 8/28/2014
Clinical Research Facility
mi
from
Tomball, TX
Click here to add this to my saved trials
Endocrinology Clinical Trial
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Status: Enrolling, Phase II
Updated: 1/24/2018
Hospital for Sick Children
mi
from
Toronto,
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
Clinical Research Facility
mi
from
Calabash, NC
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
Clinical Research Facility
mi
from
Carrollton, TX
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
Clinical Research Facility
mi
from
Lancaster, PA
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
Clinical Research Facility
mi
from
Muscle Shoals, AL
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
Clinical Research Facility
mi
from
Rosedale, NY
Click here to add this to my saved trials
Glycemic Control Clinical Trial
Comparison of TAK-875 to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 11/12/2013
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003)
Status: Enrolling, Phase III
Updated: 4/8/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003)
Status: Enrolling, Phase III
Updated: 4/8/2015
Clinical Research Facility
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003)
Status: Enrolling, Phase III
Updated: 4/8/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Endocrinology Clinical Trial
Evaluating for Type-2 Diabetes in the Very Early Postpartum Period
Status: Enrolling, Phase
Updated: 12/31/1969
NYU Winthrop Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling, Phase III
Updated: 7/6/2015
Clinical Research Facility
mi
from
Auburn, ME
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling, Phase III
Updated: 7/6/2015
Clinical Research Facility
mi
from
Avon, IN
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling, Phase III
Updated: 7/6/2015
Clinical Research Facility
mi
from
Bloomfield Hills, MI
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling, Phase III
Updated: 7/6/2015
Clinical Research Facility
mi
from
Concord, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling, Phase III
Updated: 7/6/2015
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling, Phase III
Updated: 7/6/2015
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling, Phase III
Updated: 7/6/2015
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling, Phase III
Updated: 7/6/2015
Clinical Research Facility
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling, Phase III
Updated: 7/6/2015
Clinical Research Facility
mi
from
Norman, OK
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling, Phase III
Updated: 7/6/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
mi
from
Fargo, ND
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
mi
from
Franklin, IN
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
mi
from
St Louis, MO
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
mi
from
Uniontown, PA
Click here to add this to my saved trials
Glycogen Storage Disease Type II Pompe Disease Clinical Trial
NeoGAA Extension Study
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Glycogen Storage Disease Type II Pompe Disease Clinical Trial
NeoGAA Extension Study
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Leuven,
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006)
Status: Enrolling, Phase III
Updated: 2/25/2015
Clinical Research Facility
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006)
Status: Enrolling, Phase III
Updated: 2/25/2015
Clinical Research Facility
mi
from
Midvale, UT
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006)
Status: Enrolling, Phase III
Updated: 2/25/2015
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006)
Status: Enrolling, Phase III
Updated: 2/25/2015
Clinical Research Facility
mi
from
Rancho Cucamonga, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Greer, SC
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Katy, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Springfield, MO
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling, Phase III
Updated: 2/28/2014
Clinical Research Facility
mi
from
Summerville, SC
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
Bangor, ME
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
Greenfield, IN
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
Hawaiian Gardens, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
Norman, OK
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
Opa Locka, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
Tomball, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
A Three-part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Parts II and III) (MK-2640-001)
Status: Enrolling, Phase I
Updated: 4/7/2016
Clinical Research Facility
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
The Center for Wound Healing Crozer Chester Medical Center
mi
from
Chester, PA
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
Beverly Hospital Wound and Hyperbaric Center
mi
from
Montebello, CA
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
St Joseph Mercy Oakland Hospital Center for Wound Care and Hyperbaric Medicine
mi
from
Pontiac, MI
Click here to add this to my saved trials
Type II Diabetes Mellitus Clinical Trial
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Status: Enrolling, Phase II
Updated: 12/29/2016
Clinical Research Facility
mi
from
Bountiful, UT
Click here to add this to my saved trials
Type II Diabetes Mellitus Clinical Trial
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Status: Enrolling, Phase II
Updated: 12/29/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Type II Diabetes Mellitus Clinical Trial
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Status: Enrolling, Phase II
Updated: 12/29/2016
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Type II Diabetes Mellitus Clinical Trial
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Status: Enrolling, Phase II
Updated: 12/29/2016
Clinical Research Facility
mi
from
Hawaiian Gardens, CA
Click here to add this to my saved trials
Type II Diabetes Mellitus Clinical Trial
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Status: Enrolling, Phase II
Updated: 12/29/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Type II Diabetes Mellitus Clinical Trial
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Status: Enrolling, Phase II
Updated: 12/29/2016
Clinical Research Facility
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Type II Diabetes Mellitus Clinical Trial
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Status: Enrolling, Phase II
Updated: 12/29/2016
Clinical Research Facility
mi
from
Washington, MO
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Afrezza Safety and Pharmacokinetics Study in Pediatric Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Afrezza Safety and Pharmacokinetics Study in Pediatric Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Bellaire, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Brownsburg, IN
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
mi
from
Coral Springs, FL
Click here to add this to my saved trials
1 … 31 32 33 34 35 36 37 38 39 40 41